Can stimulant meds worsen anxiety in ADHD?Â
Stimulant medications such as methylphenidate, lisdexamfetamine, and dexamfetamine are among the most effective treatments for attention deficit hyperactivity disorder (ADHD). However, many people wonder whether these medicines can make anxiety worse. According to NHS guidance on adult ADHD, stimulants can affect anxiety in different ways depending on individual factors such as dose, coexisting conditions, and how the medicine is monitored.
Clinical research summarised in the Pharmaceutical Journal and NICE guidance shows that while some people experience temporary increases in nervousness or agitation, others find that stimulants actually reduce anxiety once ADHD symptoms are better controlled. This variation highlights the importance of personalised treatment and careful monitoring.
Understanding the effects of stimulants on anxiety
Stimulants can occasionally heighten anxiety during the early stages of treatment or when doses are increased. Common side effects may include restlessness, irritability, or insomnia. Evidence from ScienceDirect suggests that up to one in four people may notice transient anxiety that often subsides with dose adjustment or continued use.
For others, stimulants can reduce anxiety by improving concentration, task management, and emotional control. Once ADHD symptoms are stabilised, adults often report feeling calmer and more confident, as daily stress becomes easier to manage.
NICE and NHS guidance
The NICE NG87 guideline and NHS recommendations advise that clinicians should always screen for anxiety and other mental health conditions before prescribing stimulants. If significant anxiety is present, options such as non-stimulant medications (for example, atomoxetine or guanfacine) may be considered. Titration should start at a low dose and increase gradually, with regular follow-up to monitor side effects or worsening anxiety.
Managing coexisting ADHD and anxiety
When ADHD and anxiety occur together, treatment usually combines medication with psychological approaches such as cognitive behavioural therapy (CBT) and psychoeducation. Shared care protocols, as outlined in NICE and NHS frameworks, recommend close collaboration between GPs and specialists to ensure safe and effective treatment.
If stimulants worsen anxiety, clinicians may reduce the dose, switch to a different formulation, or explore non-stimulant options. Atomoxetine, for example, is sometimes preferred as it can improve both ADHD and anxiety symptoms when titrated carefully.
Key takeaway
Stimulant medication can affect anxiety in different ways, sometimes worsening it temporarily but often improving it as ADHD symptoms are managed. Following NICE and NHS guidance, clinicians tailor treatment, start with low doses, and use combined behavioural support to keep both conditions under control. With careful monitoring, stimulant therapy can be both safe and effective for people living with ADHD and coexisting anxiety.
